Publications

Export 111 results:
Sort by: [ Author  (Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Vitale, A., F. Della Casa, G. Ragab, I. A. Almaghlouth, G. Lopalco, R. M. Pereira, S. Guerriero, M. Govoni, P. P. Sfikakis, R. Giacomelli, et al., "Development and implementation of the AIDA International Registry for patients with Behçet’s disease", Internal and Emergency Medicine: Springer Science and Business Media Deutschland GmbH, 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Vitale, A., F. Della Casa, G. Lopalco, R. M. Pereira, P. Ruscitti, R. Giacomelli, G. Ragab, F. La Torre, E. Bartoloni, E. Del Giudice, et al., "Development and Implementation of the AIDA International Registry for Patients With Still's Disease", Frontiers in Medicine, vol. 9: Frontiers Media S.A., 2022. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
T
Treppo, E., L. Quartuccio, G. Ragab, and S. De Vita, "Rheumatologic manifestations of Hepatitis C Virus.", Minerva Medica, 2020. Abstract
n/a
Treppo, E., L. Quartuccio, G. Ragab, and S. De Vita, "Rheumatologic manifestations of Hepatitis C Virus", Minerva Medica, vol. 112, issue 2: Edizioni Minerva Medica, pp. 201 - 214, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
S
Sota, J., D. Rigante, R. Cimaz, M. Cattalini, M. Frassi, R. Manna, L. L. Sicignano, E. Verrecchia, E. Aragona, and M. C. Maggio, "Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry", Rheumatology, 2021. Abstract
n/a
Sota, J., D. Rigante, R. Cimaz, M. Cattalini, M. Frassi, R. Manna, L. L. Sicignano, E. Verrecchia, E. Aragona, M. C. Maggio, et al., "Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry", Rheumatology (United Kingdom), vol. 60, issue 12: Oxford University Press, pp. 5705 - 5712, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
R
REFAAT, M., A. M. Abdullatif, M. M. Hamza, T. A. Macky, M. - S. H. El-Agha, G. Ragab, and M. M. Soliman, "MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study", Retina (Philadelphia, Pa.), vol. 41, issue 8: NLM (Medline), pp. 1739 - 1747, 2021. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Refaat, M., A. M. Abdullatif, M. M. Hamza, T. A. Macky, M. H. El-Agha, G. Ragab, and M. M. Soliman, "Monthly Intravitreal Infliximab in Behçet's Disease Active Posterior Uveitis: A Long-Term Safety Study.", Retina (Philadelphia, Pa.), 2020. Abstract
n/a
Ramos-Casals, M., A. L. Zignego, C. Ferri, P. Brito-Zeron, S. Retamozo, M. Casato, P. Lamprecht, A. Mangia, D. Saadoun, and A. G. Tzioufas, "Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection", Journal of Hepatology, vol. 66, issue 6: Elsevier, pp. 1282-1299, 2017. Abstract
n/a
Ramos-Casals, M., A. L. Zignego, C. Ferri, P. Brito-Zerón, S. Retamozo, M. Casato, P. Lamprecht, A. Mangia, D. Saadoun, A. G. Tzioufas, et al., "Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection", Journal of Hepatology, vol. 66, no. 6: Elsevier {BV}, pp. 1282–1299, jun, 2017. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., M. T. Hegazy, M. Ali, M. R. E. Abdel-Halim, and X. Puéchal, "Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis", Journal of Advanced Research, vol. 24: Elsevier B.V., pp. 311 - 315, 2020. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., and M. A. Hussein, "Vasculitic syndromes in hepatitis C virus: A review", Journal of advanced research, vol. 8, issue 2: Elsevier, pp. 99-111, 2017. Abstract
n/a
Ragab, G., C. Dehner, H. Hamza, and M. Kriegel, "Systemic Lupus Erythematosus", The Microbiome in Rheumatic Diseases and Infection: Springer, 2018.
Ragab, M., "Oral Direct Anticoagulants in Thrombosis Management in Anti-Phospholipid Syndrome: Unanswered Questions", J Hematol Thrombo Dis, vol. 3, issue 208: http://www.esciencecentral.org/journals/oral-direct-anticoagulants-in …, 2015. Abstract
n/a
Ragab, G., W. Ruff, D. Pearson, H. Goubran, and M. Kriegel, "Antiphospholipid Syndrome", The Microbiome in Rheumatic Diseases and Infection: Springer, pp. 305-321, 2018. Abstract
n/a
Ragab, G., C. Dehner, H. Hamza, and M. Kriegel, "Systemic lupus erythematosus", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 285 - 304, 2018. Abstract
n/a
Ragab, G., M. A. El-Ghobary, and R. M. Elgohary, "The importance of using ultrasonography in knee osteoarthritis", The Egyptian Journal of Internal Medicine, vol. 24, issue 3: SpringerOpen, pp. 93-96, 2012. Abstract
n/a
Ragab, G., W. Ruff, D. Pearson, H. Goubran, and M. Kriegel, "Antiphospholipid syndrome", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 305 - 321, 2018. Abstract
n/a
Ragab, G., "Chapter 15: Vasculitic manifestations in the gastrointestinal tract", Vasculitis: Oxford University Press, pp. 181-198, 2008. Abstract
n/a
Ragab, G., M. A. El-Ghobary, R. M. Elgohary, and others, "The importance of using ultrasonography in knee osteoarthritis", The Egyptian Journal of Internal Medicine, vol. 24, no. 3: Medknow Publications, pp. 93, 2012. Abstract
n/a
Ragab, G., C. Dehner, H. Hamza, and M. Kriegel, "Systemic Lupus Erythematosus", The Microbiome in Rheumatic Diseases and Infection: Springer, pp. 285-304, 2018. Abstract
n/a
Ragab, G., W. Ruff, D. Pearson, H. Goubran, and M. Kriegel, "Antiphospholipid Syndrome", The Microbiome in Rheumatic Diseases and Infection: Springer, 2018.
Ragab, G., M. T. Hegazy, M. Ali, M. R. E. Abdel-Halim, and X. Puéchal, "Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis", Journal of Advanced Research, vol. 24: Elsevier, pp. 311-315, 2020. Abstract
n/a
Ragab, G., and M. A. Hussein, "Vasculitic syndromes in hepatitis C virus: A review", Journal of Advanced Research, vol. 8, no. 2, pp. 99 - 111, 2017. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., and H. Rizk, "Subacute Bacterial Endocarditis", The Microbiome in Rheumatic Diseases and Infection: Springer, pp. 391-401, 2018. Abstract
n/a
Ragab, G., and H. Rizk, "Subacute bacterial endocarditis", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 391 - 401, 2018. Abstract
n/a
Ragab, G., "Vasculitic manifestations in the gastrointestinal tract", Oxford Textbook of Vasculitis: Oxford University Press, pp. 179-195, 2014. Abstract
n/a
Ragab, G., and M. A. Hussein, "Vasculitic syndromes in hepatitis C virus: A review", Journal of Advanced Research, vol. 8, issue 2: Elsevier B.V., pp. 99 - 111, 2017. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., P. T. Atkinson, and M. L. Stoll, The Microbiome in Rheumatic Diseases and Infection, : Springer, 2018.
Ragab, G., M. Elshahaly, and T. Bardin, "Gout: An old disease in new perspective – A review", Journal of Advanced Research, vol. 8, issue 5: Elsevier B.V., pp. 495 - 511, 2017. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., "Vasculitic manifestations in the gastrointestinal tract", Oxford Textbook of Vasculitis: Oxford University Press, 2014.
Ragab, G., and H. Rizk, "Subacute Bacterial Endocarditis", The Microbiome in Rheumatic Diseases and Infection: Springer, 2018.
Ragab, G., P. T. Atkinson, and M. L. Stoll, The Microbiome in Rheumatic Diseases and Infection, : Springer, 2018. Abstract
n/a
Ragab, G., M. T. Hegazy, V. Codullo, M. Mattar, and J. Avouac, "Anticoagulation in Autoimmune Rheumatic Diseases", Precision Anticoagulation Medicine: Springer, Cham, pp. 159-179, 2020. Abstract
n/a
Ragab, G., M. Elshahaly, and T. Bardin, "Gout: An old disease in new perspective–A review", Journal of advanced research, vol. 8, issue 5: Elsevier, pp. 495-511, 2017. Abstract
n/a
Ragab, G., T. P. Atkinson, and M. L. Stoll, "The microbiome in rheumatic diseases and infection", The Microbiome in Rheumatic Diseases and Infection: Springer International Publishing, pp. 1 - 490, 2018. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Ragab, G., H. El-Gendy, and R. M. El-Gohary, Musculoskeletal Disorders and Treatment, , 2017. Abstract
n/a
Q
Quartuccio, L., L. Corazza, M. Ramos-Casals, S. Retamozo, G. M. Ragab, G. Ferraccioli, E. Gremese, A. Tzioufas, M. Voulgarelis, D. Vassilopoulos, et al., "OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins", Annals of the Rheumatic Diseases, vol. 74, issue Suppl 2, pp. 175-176, June 1, 2015. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ

Background Serum cryoglobulins (SC) may be found in many diseases (1), and the presence of serum cryoglobulins is a known risk factor for lymphoma evolution in some non malignant diseases.Objectives The aim of this study was to distiguish the role of cryoglobulinemic vasculitis (CV), classified according to the recent validated criteria (1,2), and primary Sjögren's syndrome (pSS) as risk factors of lymphoma in patients positive serum cryoglobulins. Importantly, SC, CV and pSS may occur together.Methods 950 charts from consecutive patients with positive SC were evaluated. Patients carrying both pSS and HCV infection, as well as incomplete charts, were excluded.Results 657 patients with SC were selected, 374 with CV and 283 without CV, according to the published criteria (2,3). PSS, classified according to the American-European Group Criteria was present in 96 patients (44 with CV, 52 without). Lymphoma was reported in 61/657 (9.8%) patients with SC. Among them, CV was present in 44/61 (72,1%; 14 also with pSS), and pSS in 17/61 (27,9%; and 14/17 had CV). Patients with SC with CV showed an higher prevalence of lymphoma than patients with SC without CV (44/374, 11.5% vs.17/283, 6.3%; p=0.025, OR=1.93 [95%IC: 1.08-3.39]. Patients with pSS, SC and CV also showed a higher prevalence of lymphoma than patients with pSS, SC but without CV (14/44, 31.8% vs. 3/52, 7.4%; p=0.001, OR=7.62 [95%CI 2.02-28.74]. CV and pSS were confirmed as independent risk factor for lymphoma by multivariate analysis (OR 2,18 95%CI 1,18-3,83, p=0,012; OR 2,65 95%CI 1,04-6,76, p=0,042, respectively). Infection by the hepatitis C virus (HCV) was detected in 467/561 (83,2%) patients with SC without pSS, and did not statistically predispose to lymphoma when associated with CV in this subset (p=1,0).Conclusions Cryoglobulinemic vasculitis and pSS are independent risk factors for lymphoma in patients with evidence of SC. Patients with both the conditions (CV and pSS) have the highest risk. In the follow-up of SC positive patients, a very high attention should be deserved to pSS, in particular when CV is present.ReferencesDe Vita S, et al. Ann Rheum Dis. 2011; 2) Quartuccio L, et al. Rheumatology (Oxford). 2014Disclosure of Interest None declared

Quartuccio, L., M. Isola, L. Corazza, M. Ramos-Casals, S. Retamozo, G. M. Ragab, M. N. Zoheir, M. A. - M. El-Menyawi, M. N. Salem, and D. Sansonno, "Validation of the classification criteria for cryoglobulinaemic vasculitis", Rheumatology, vol. 53, issue 12: Oxford University Press, pp. 2209-2213, 2014. Abstract
n/a
Quartuccio, L., M. Isola, L. Corazza, S. Retamozo, M. A. - M. El-Menyawi, E. Gremese, M. Sebastiani, N. Pipitone, T. Urraro, V. Conteduca, et al., "Validation Study Of The International Classification Criteria For The Cryoglobulinemic Vasculitis", ARTHRITIS AND RHEUMATISM, vol. 65, pp. S1123–S1124, 2013. Abstract
n/a